6533b7cffe1ef96bd1259a43

RESEARCH PRODUCT

Coagulation Parameters: An Efficient Measure for Predicting the Prognosis and Clinical Management of Patients with COVID-19

Vicente Gea-caballeroBárbara Olivan-blázquezEva María Andrés-estebanManuel Quintana-díazKaren Lizzette Ramírez-cervantesRaúl Juárez-velaHttp://orcid.org/0000-0001-8607-3195Http://orcid.org/0000-0001-6565-9699Http://orcid.org/0000-0001-5083-1978Http://orcid.org/0000-0003-3597-2048

subject

Pediatricsmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)coronaviruslcsh:Medicine030204 cardiovascular system & hematologymedicine.disease_causeArticle03 medical and health sciences0302 clinical medicineInterquartile rangePandemicMedicine030212 general & internal medicinecoagulationCoronavirusSARS-CoV-2business.industrylcsh:RCOVID-19Respiratory infectionRetrospective cohort studyGeneral MedicineCoagulationCOVID-19 SARS-CoV-2 coagulation coronavirusCohortbusiness

description

Background. COVID-19 is an ongoing global pandemic. Since the detection of the first cases of coronavirus disease 2019 (COVID-19) in Wuhan, China, the current pandemic has affected more than 25.3 million people worldwide. The aim of this study was to evaluate the relationship between coagulation abnormalities and prognosis in a cohort of patients with COVID-19. Methods. We performed a retrospective cohort study of 3581 patients admitted to Hospital La Paz (Madrid, Spain) due to respiratory infection by severe acute respiratory syndrome coronavirus from the beginning of the current pandemic to 15 July 2020. Results. Of the 3581 study patients, 48.94% were men, and 19.80% were healthcare workers. The median age was 62 years. Compared with the survivors, the non-survivors had lower prothrombin activity (82.5 ( Interquartile range -IQR-, 67&ndash

yearjournalcountryeditionlanguage
2020-10-01
http://zaguan.unizar.es/record/98195